Lysosomal cystine accumulation activates mTOR signaling in cystinosis: are mTOR inhibitors the cure? No … ← Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphoma Post-Transplant Lymphoproliferative Disorders (Review for Seminars in Nephrology) →